Bibliographic Info
GuidelineGuidelines for treatment of drug-susceptible tuberculosis and patient care
Year of Publication2017
Issuing InstitutionWorld Health Organization
Recommendation
Status
Maintained
Recommended in favor
Conditional
Certainty of evidence
Low
The use of fixed-dose combination (FDC) tablets is recommended over separate drug formulations in the treatment of patients with drug-susceptible TB
Also Featured In
This recommendation also appears in the following guidelines:
Guideline
WHO consolidated guidelines on tuberculosis: module 4: treatment: drug-susceptible tuberculosis treatment.
Year2022
InstitutionWHO
Guideline
WHO consolidated guidelines on tuberculosis: module 4: treatment and care
Year2025
InstitutionWorld Health Organization